Kodiak Sciences Inc (KOD)
8.4700  +0.1000 (1.19%)

Kodiak Sciences Inc. is a biopharmaceutical company focused on developing breakthrough therapeutic treatments for retinal diseases and other serious eye conditions. The company specializes in creating innovative therapies that harness the potential of biologics to address significant unmet medical needs in the field of ophthalmology. Its research is aimed at providing long-term solutions with the goal of improving patients' vision and quality of life, while also reducing the burden on healthcare systems. Through its advanced drug development programs, Kodiak is committed to pioneering new standards of care in eye health.

SummaryNewsPress ReleasesChartHistorical
Previous Close8.370
Open8.430
Bid8.190
Ask8.500
Day's Range8.180 - 8.781
52 Week Range2.185 - 11.60
Volume325,694
Market Cap444.28M
PE Ratio (TTM)-2.321
EPS (TTM)-3.6
Dividend & YieldN/A (N/A)
1 Month Average Volume493,307

News & Press Releases

12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · December 9, 2024
Pactiv Evergreen, RealReal, Kodiak Sciences And Other Big Stocks Moving Higher On Mondaybenzinga.com
Via Benzinga · December 9, 2024
Eye-Disease Focused Kodiak Sciences Is A Promising 'Turnaround Story For 2025': Analyst Upgrades Stockbenzinga.com
Jefferies upgrades Kodiak Sciences, citing undervaluation and growth potential as Phase 3 trials advance for tarcocimab in retinal diseases.
Via Benzinga · December 9, 2024
KOD Stock Earnings: Kodiak Sciences Beats EPS for Q2 2024investorplace.com
KOD stock results show that Kodiak Sciences beat analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 14, 2024
KOD Stock Earnings: Kodiak Sciences Beats EPS for Q1 2024investorplace.com
KOD stock results show that Kodiak Sciences beat analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 15, 2024
Preview: Kodiak Sciences's Earningsbenzinga.com
Via Benzinga · March 27, 2024
Eye Disease-Focused Kodiak Reboots Once Shelved Tarcocimab Development Programbenzinga.com
Kodiak Sciences Inc (NASDAQ: KOD) 
Via Benzinga · November 6, 2023
Expert Ratings for Kodiak Sciencesbenzinga.com
Via Benzinga · July 27, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · April 3, 2024
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · March 29, 2024
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · March 28, 2024
KOD Stock Earnings: Kodiak Sciences Misses EPS for Q4 2023investorplace.com
KOD stock results show that Kodiak Sciences missed analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · March 28, 2024
US Stocks Flat; Initial Jobless Claims Fall To 210,000benzinga.com
U.S. stocks traded mixed this morning, with the Dow Jones index trading almost flat on Thursday. Following the market opening Thursday, the Dow traded down 0.02% to 39,753.17 while the NASDAQ fell 0.08% to 16,385.80. The S&P 500 also rose, gaining, 0.04% to 5,250.38.
Via Benzinga · March 28, 2024
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Sessionbenzinga.com
Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share.
Via Benzinga · March 28, 2024
Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Sessionbenzinga.com
Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition.
Via Benzinga · December 11, 2023
Earnings Scheduled For March 28, 2024benzinga.com
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.
Via Benzinga · March 28, 2024
Why Dolby Laboratories Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Sessionbenzinga.com
Shares of Dolby Laboratories, Inc. (NYSE: DLB) fell during Friday’s session following weak guidance.
Via Benzinga · November 17, 2023
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · November 17, 2023
Why StoneCo Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarketbenzinga.com
StoneCo Ltd. (NASDAQ: STNE) shares rose in pre-market trading after the company reported upbeat results for its third quarter on Friday.
Via Benzinga · November 13, 2023
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Mondayinvestorplace.com
We're starting off the trading week right with a breakdown of the biggest pre-market stock movers worth noting on Monday morning!
Via InvestorPlace · November 6, 2023
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yetbenzinga.com
The Benzinga Stock Whisper Index uses proprietary data to look at stocks with increased interest from investors.
Via Benzinga · November 3, 2023
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Sessionbenzinga.com
Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders.
Via Benzinga · November 2, 2023
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · November 2, 2023
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 17, 2023
Why WestRock Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarketbenzinga.com
Gainers
Via Benzinga · September 7, 2023